Showing results (271-280 of 304) with videos related to

Sort By:
Pageof 31
Frontiers in Oncology|April 1, 2022
Solid Tumor Opioid Receptor Expression and Oncologic Outcomes: Analysis of the Cancer Genome Atlas and Genotype Tissue Expression ProjectAmparo Belltall, Sheila Zúñiga-Trejos, Iris Garrido-Cano, et al.
Blood|January 27, 2012
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemiaMartin F M de Rooij, Annemieke Kuil, Christian R Geest, et al.
Molecular Cancer Therapeutics|May 30, 2006
CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivoJoseph J Buggy, Z Alexander Cao, Kathryn E Bass, et al.
Annals of Hematology|September 3, 2014
Modeling absolute lymphocyte counts after treatment of chronic lymphocytic leukemia with ibrutinibDavid D Smith, Leanne Goldstein, Mei Cheng, et al.
British Journal of Pharmacology|May 22, 2008
Activation of the spinal sigma-1 receptor enhances NMDA-induced pain via PKC- and PKA-dependent phosphorylation of the NR1 subunit in miceH-W Kim, D-H Roh, S-Y Yoon, et al.
Leukemia|November 26, 2013
BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activityS Cheng, J Ma, A Guo, et al.
Journal of Neuroendocrinology|January 22, 2003
The anti-inflammatory effect of bee venom stimulation in a mouse air pouch model is mediated by adrenal medullary activityY-B Kwon, H-W Kim, T-W Ham, et al.
BMJ Open|October 30, 2024
Assessing the relative efficacy of components of opioid-free anaesthesia in adult surgical patients: protocol for a systematic review and component network meta-analysisAmparo Belltall, Guido Mazzinari, Aisling Ní Eochagáin, et al.
Cancer Immunology Research|August 23, 2018
A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti-PD-(L)1 and Anti-CTLA-4 in Preclinical ModelsStephen B Willingham, Po Y Ho, Andrew Hotson, et al.
Blood|December 20, 2011
The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivoSabine Ponader, Shih-Shih Chen, Joseph J Buggy, et al.
Pageof 31